Whole Blood DNA Extraction Methods Compared
|
By LabMedica International staff writers Posted on 14 Aug 2014 |
In the clinical laboratory, nucleic acids are routinely isolated from various types of specimen, including blood, sputum, cerebrospinal fluid, stool, urine, buccal swabs, and respiratory specimens, for use in a wide array of molecular diagnostic tests.
Both the quality and quantity of the extracted nucleic acids are crucial to the successful implementation of downstream molecular diagnostic procedures, including polymerase chain reaction (PCR), quantitative PCR, microarray analyses, and direct sequencing.
Laboratory scientists at the Asian Medical Center (Seoul, Republic of Korea) collected blood samples from five healthy donors and all DNA extraction processes were performed within six hours of specimen collection. The team evaluated the efficiency of three extraction methods by comparison based on the total amount of extracted DNA adjusted by input blood volume, and the purity of the extract. Polymerase chain reaction analyses were performed using the Actin Beta gene (ACTB) as a target. The real-time PCR assay was carried out for housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Total elapsed time for DNA extraction was compared.
The three extraction methods were the Nextractor NX-48 system, (Genolution; Seoul, Republic of Korea); the manual QIAamp DNA Blood Mini Kit (Qiagen; Valencia, CA, USA), and the automated Maxwell system method (Promega; Madison, WI, USA). Following DNA extraction, the optical density of each sample was read at 260 nm and 280 nm using a NanoDrop ND-2000c spectrophotometer (Thermo Scientific; Wilmington, DE, USA). Real-time PCR was run on a SmartCycler system (Cepheid; Sunnyvale, CA, USA).
Extraction efficiencies for the QIAamp was 25.4 ± 3.8 ng/μL, for the Maxwell it was 9.2 ± 0.6 ng/μL, and the Nextractor system was the most efficient at 31.0 ± 5.6 ng/μL. No significant differences in purity were observed among three methods. DNA extracted using the ACTB was successfully amplified in all three methods. There were no obvious differences in cycle threshold (Ct) values for GAPDH real-time PCR. Total elapsed time for DNA extraction was about 50 minutes for the QIAamp, 40 minutes for the Maxwell, and 20 minutes for the Nextractor.
The authors concluded that both the purity and yield of the Nextractor system were similar to that of manual extraction. The relative speed and low hands-on time represent clear benefits over manual processes. Therefore, the Nextractor system represents a useful alternative to manual DNA extraction in clinical laboratories that is suitable for many downstream molecular diagnostic applications. The study was published in the August 2014 issue of the journal Clinica Chimica Acta.
Related Links:
Asian Medical Center
Genolution
Cepheid
Both the quality and quantity of the extracted nucleic acids are crucial to the successful implementation of downstream molecular diagnostic procedures, including polymerase chain reaction (PCR), quantitative PCR, microarray analyses, and direct sequencing.
Laboratory scientists at the Asian Medical Center (Seoul, Republic of Korea) collected blood samples from five healthy donors and all DNA extraction processes were performed within six hours of specimen collection. The team evaluated the efficiency of three extraction methods by comparison based on the total amount of extracted DNA adjusted by input blood volume, and the purity of the extract. Polymerase chain reaction analyses were performed using the Actin Beta gene (ACTB) as a target. The real-time PCR assay was carried out for housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Total elapsed time for DNA extraction was compared.
The three extraction methods were the Nextractor NX-48 system, (Genolution; Seoul, Republic of Korea); the manual QIAamp DNA Blood Mini Kit (Qiagen; Valencia, CA, USA), and the automated Maxwell system method (Promega; Madison, WI, USA). Following DNA extraction, the optical density of each sample was read at 260 nm and 280 nm using a NanoDrop ND-2000c spectrophotometer (Thermo Scientific; Wilmington, DE, USA). Real-time PCR was run on a SmartCycler system (Cepheid; Sunnyvale, CA, USA).
Extraction efficiencies for the QIAamp was 25.4 ± 3.8 ng/μL, for the Maxwell it was 9.2 ± 0.6 ng/μL, and the Nextractor system was the most efficient at 31.0 ± 5.6 ng/μL. No significant differences in purity were observed among three methods. DNA extracted using the ACTB was successfully amplified in all three methods. There were no obvious differences in cycle threshold (Ct) values for GAPDH real-time PCR. Total elapsed time for DNA extraction was about 50 minutes for the QIAamp, 40 minutes for the Maxwell, and 20 minutes for the Nextractor.
The authors concluded that both the purity and yield of the Nextractor system were similar to that of manual extraction. The relative speed and low hands-on time represent clear benefits over manual processes. Therefore, the Nextractor system represents a useful alternative to manual DNA extraction in clinical laboratories that is suitable for many downstream molecular diagnostic applications. The study was published in the August 2014 issue of the journal Clinica Chimica Acta.
Related Links:
Asian Medical Center
Genolution
Cepheid
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Molecular Diagnostics News
- Blood-Based DNA Analysis Method Detects Early-Stage Solid Cancers
- Combined Blood and Genetic Tests Estimate Timing of Alzheimer’s Symptom Onset
- Blood Protein Analysis Helps Interpret Uncertain Rare Disease Variants
- 40-Gene Test Validated for High-Risk Squamous Cell Carcinoma
- Blood Test Helps Clarify Prostate Cancer Risk After Elevated PSA
- Common Genetic Marker Predicts Faster Motor Decline in Parkinson’s Disease
- DPYD Genotyping Assay Supports Safer Fluoropyrimidine Chemotherapy Dosing
- Secure Cloud-Connected qPCR System Enables Remote Infectious Disease Surveillance
- Project to Develop Maternal Blood Test for Rapid Fetal Oxygen Deprivation Detection
- WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response
- FDA Clears Liquid Biopsy Test to Guide Earlier Breast Cancer Therapy Switch
- Automated System Streamlines DNA Recovery for MRD-Sensitive Testing
- New Liquid Biopsy Platform Uses Red Blood Cells to Detect Hidden Cancer Signals
- Urine Genomic Test Detects More Than Nine in Ten Suspected Bladder Cancers
- Liquid Biopsy Test Predicts Tissue of Origin in Cancer of Unknown Primary
- Study Identifies Genetic Marker Missing from Common Pharmacogenomic Panels
Channels
Clinical Chemistry
view channel
Childhood Blood Biomarkers May Reveal Early Heart, Kidney, and Metabolic Risks
Cardiovascular, kidney, and metabolic disorders often begin with subtle biological changes that are difficult to recognize in childhood. Identifying these changes early... Read more
Blood Biomarker Study Reveals Early Signals of Future Cognitive Difficulties
Alzheimer’s disease develops silently over many years, while subtle memory changes can elude standard cognitive testing. Blood-based measures are being explored as scalable, minimally invasive tools for... Read more
New Reference Material Aims to Improve Comparability of Angiotensin II Testing
Comparability of biomarker measurements across laboratories remains a persistent hurdle for clinical decision-making and method development. Angiotensin II, a peptide hormone central to blood pressure... Read more
International Consensus Guidance Outlines General Population Screening for Early-Stage Type 1 Diabetes
Type 1 diabetes (T1D) is an autoimmune disease that can develop in childhood or adulthood and affects an estimated 9.5 million people worldwide. Its complications range from acute diabetic ketoacidosis... Read moreHematology
view channel
Hidden Molecular Mechanism Behind HIT Blood-Clotting Disorder Revealed
Immune-mediated thrombosis following heparin therapy can be sudden and severe, creating urgent diagnostic challenges. In heparin-induced thrombocytopenia (HIT), antibodies against platelet factor 4 (PF4)... Read more
Borderline Anemia May Carry Higher Risk Than Current Thresholds Suggest
Hemoglobin concentration is among the most frequently ordered blood tests in primary and hospital care. In older adults, both high and low values have been linked to adverse outcomes, including cognitive... Read moreImmunology
view channel
New Cellular Map May Help Predict Crohn’s Disease Course in Children
Crohn’s disease in children is a common and debilitating form of inflammatory bowel disease, marked by chronic intestinal inflammation and limited pediatric-specific treatments. Clinicians must decide... Read more
Temporal Immune Profiling Reveals How Sepsis States Change Over Time
Sepsis is a life-threatening condition in which the immune response to infection becomes dysregulated, leading to rapid organ failure and death. Although antimicrobials and organ support remain standard... Read more
Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19
Autoantibodies that mistakenly attack the body’s own tissues have been linked to severe COVID-19, Long COVID, and increased risk of autoimmune disease. However, the origins of these autoantibodies during... Read moreMicrobiology
view channel
Infant Skin Microbiome Show Links to Later Eczema and Food Allergies
Eczema, or atopic dermatitis, and food allergies often begin in infancy and are among the earliest stages of the atopic march. Atopic dermatitis alone can affect up to 20% of children, yet objective indicators... Read more
Diagnostic Stewardship Guide Targets Testing Overuse and Hospital Cost Pressures
Hospitals face persistent pressure to improve diagnostic accuracy while reducing unnecessary testing and costs. Misordered or overused assays can complicate infection metrics, trigger penalties, and strain... Read more
Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics
Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read morePathology
view channel
AI Spatial Analysis of Routine Slides Helps Predict Pancreatic Cancer Recurrence
Predicting which patients with pancreatic cancer will recur after treatment and surgery remains challenging. Pathology evaluation typically measures residual tumor burden, but recent work found that tumor... Read more
Hybrid Computational Imaging Method Improves Digital Pathology Resolution
Digital pathology depends on high-resolution whole-slide imaging to capture diagnostically relevant cellular and tissue features, yet conventional methods often force trade-offs between speed, cost, and detail.... Read moreTechnology
view channel
Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions
Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more
New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling
Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more
Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins
Recombinant proteins are central to many cancer diagnostics and therapies, but numerous targets remain difficult and costly to produce because they are unstable, toxic to microbial hosts, or require precise folding.... Read moreIndustry
view channel
Blood-Based Neurology Biomarker Assays Authorized for Use in Brazil
H.U. Group Holdings Inc. (Tokyo, Japan) and its wholly owned subsidiary Fujirebio announced that the Brazilian Health Regulatory Agency (ANVISA) has authorized the Lumipulse G NfL Blood and Lumipulse G... Read more








